Michela Squadroni
Overview
Explore the profile of Michela Squadroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fazio N, Gervaso L, Halfdanarson T, Sonbol M, Eiring R, Pusceddu S, et al.
Endocr Relat Cancer
. 2023 Mar;
30(6).
PMID: 36930250
We conducted a retrospective/prospective worldwide study on patients with neuroendocrine neoplasms (NENs) and a molecularly proven SARS-CoV-2 positivity. Preliminary results regarding 85 patients of the INTENSIVE study have been published...
2.
Canziani L, Trovati S, Brunetta E, Testa A, De Santis M, Bombardieri E, et al.
J Autoimmun
. 2020 Jul;
114:102511.
PMID: 32713677
In cases of COVID-19 acute respiratory distress syndrome, an excessive host inflammatory response has been reported, with elevated serum interleukin-6 levels. In this multicenter retrospective cohort study we included adult...
3.
Di Noia V, DAveni A, Squadroni M, Beretta G, Ceresoli G
Lung Cancer
. 2020 May;
145:208-210.
PMID: 32439211
No abstract available.
4.
Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R
Crit Rev Oncol Hematol
. 2017 Jul;
116:11-31.
PMID: 28693792
Biliary tract cancer accounts for <1% of all cancers and affects chiefly an elderly population, with predominance in men. We distinguish cholangiocarcinoma (intrahepatic, hilar and distal) and gallbladder cancer, with...
5.
Beretta G, Petrelli F, Stinco S, Cabiddu M, Ghilardi M, Squadroni M, et al.
Med Oncol
. 2013 Feb;
30(1):486.
PMID: 23400961
Irinotecan and infusional 5-fluorouracil-based chemotherapy (FOLFIRI) plus bevacizumab (FOLFIRI-B) is one of the most effective treatments of advanced colorectal cancer (CRC). However, this schedule is regarded more extensively as first-line...
6.
Spada F, Squadroni M, Lorizzo K, Farris A, Fazio N
Tumori
. 2012 Jun;
98(2):53e-56e.
PMID: 22678005
Among primary liver cancers occurring worldwide, hepatocellular carcinoma (HCC) is the major histological type accounting for 70-85% of all cases. Phase III trials in patients with advanced HCC treated with...
7.
Fazio N, Cinieri S, Lorizzo K, Squadroni M, Orlando L, Spada F, et al.
Cancer Treat Rev
. 2010 Dec;
36 Suppl 3:S87-94.
PMID: 21129617
Enteropancreatic (EP) neuroendocrine carcinomas (NECs) represent relatively rare and heterogeneous malignancies. They are the most common group among neuroendocrine tumors (NETs). In most cases they are advanced at diagnosis and...
8.
Lorizzo K, Fazio N, Radice D, Boselli S, Ariu L, Giulia Zampino M, et al.
Cancer Chemother Pharmacol
. 2008 Nov;
64(2):301-6.
PMID: 19034450
Purpose: Second-line chemotherapy in patients with metastatic gastric cancer (MGC) pre-treated with cisplatin is not a standard option. We studied a combination of irinotecan, fluorouracil and folates. Methods: Patients progressive...
9.
Cascinu S, Scartozzi M, Carbonari G, Pierantoni C, Verdecchia L, Mariani C, et al.
Am J Clin Oncol
. 2007 Oct;
30(5):526-30.
PMID: 17921715
Objective: The attempt to improve therapeutic results in pancreatic carcinoma has recently focused on the emerging role of molecular biology. We investigated the role of COX-2 and NF-KB expression in...
10.
Berardi R, Rossana B, Scartozzi M, Mario S, Freddari F, Federica F, et al.
Cancer Treat Rev
. 2006 Jun;
32(5):333-47.
PMID: 16762510
Biliary tract cancer is a quite rare disease; despite recent significant advances in imaging modalities, most of the patients have advanced disease at presentation thus making radical surgery not feasible....